Massachusetts General Hospital

Category

Massachusetts General Hospital Completes Study & Concludes Tocilizumab Not Helpful for Hospitalized COVID-19 Patients

TrialSite has reported on a few different study results indicating that Roche’s Actemra (tocilizumab), an IL-6 inhibitor, doesn’t help to lower the death rate for hospitalized patients infected with severe to critical COVID-19. Now study results, recently published in...

Massachusetts General Hospital to Commence Trial Investigating the Correlation of BCG Vaccine to COVID-19 Health Improvements

Massachusetts General Hospital plans on launching a clinical trial based on a century-old tuberculosis vaccine that can offer protection against a variety of other infections and potentially be applicable to COVID-19. A small but vocal group have identified a...

Massachusetts General Hospital Enrolls COVID-19 Patients in Clinical Trial of Remdesivir

The Infectious Disease Division at Massachusetts General Hospital (MGH) is the first center in New England to enroll patients in an international study of remdesivir, the antiviral drug with an aim to treat those afflicted with COVID-19. Background The study’s...

Translational Research at Work—Pancreatic Cancer Network Research Leads to Promising Treatment for Locally Advanced Pancreatic Cancer

Pancreatic Cancer Action Network reports on an innovative new combination treatment for pancreatic cancer incorporating chemotherapy and radiation therapy with a common blood pressure drug (losartan). The combination treatment is promising in an early-phase clinical...

Pin It on Pinterest